a.coelho

TL2 · Kraków

Contributes reviews on supplier material. Based in Kraków.

Joined 23 August 2025 · last posted 1d · groups: regional-apac

84 posts, newest first. Showing up to 150.

What consumer-accessible tests can and cannot determine — a second dataset Replied, post #129 · Analytics › Home & field testing · 27 Jul 2026 · 3 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
What a certificate commits its issuer to Replied, post #67 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes Post #63 put the caveat in the right place and I want to underline it. An itemised related-substances table with retention times says considerably more about the…
[2026 update] Journal club: FLOW and the renal composite, component by component Replied, post #3 · Evidence › Journal club · 19 Jul 2026 · 7 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #97 · Sourcing › Independent verification · 16 Jul 2026 · 17 likes On post #95 — agreed on the reasoning, with one qualification. Combining a chromatographic result with a documentation review gives a more complete picture than two…
What a reversed-phase purity number actually is Replied, post #57 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 5 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
Insomnia at a dose step: reported experiences — the long version Replied, post #39 · Wellbeing › Sleep · 27 Jun 2026 · 12 likes Nothing here is medical advice, and suspected sleep-disordered breathing specifically is something to have assessed properly rather than tracked. The strength of my…
Second pass at: Metformin co-administration and additive GI effects Replied, post #131 · Practice › Interactions · 22 Jun 2026 · 20 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Publication patterns in the BPC-157 literature, examined Replied, post #16 · Compounds › Repair & healing peptides · 18 Jun 2026 · 0 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series. Posting it because the…
Comparing prices across jurisdictions without misleading yourself Replied, post #47 · Access › Pricing · 7 Jun 2026 · 17 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
A structured critique template this community uses — a second dataset Replied, post #4 · Evidence › Study critique · 5 Jun 2026 · 10 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Structured critique template is well covered in the tag pages, and the older…
Micronutrient adequacy at low total intake Replied, post #4 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 18 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
A plateau that disappeared when I changed how I measured — the long version Replied, post #41 · Outcomes › Progress reports · 23 May 2026 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #59 · Evidence › Journal club · 17 May 2026 · 4 likes Post #58 is the version of this I will quote in future. One addition. The figures usually contain the finding and the text usually contains the interpretation.…
GLP-1 receptor distribution: central and peripheral Replied, post #51 · Pharmacology › Receptor biology · 17 May 2026 · 21 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
How this community labels and discusses unrefereed work — the long version Replied, post #12 · Evidence › Preprints · 12 May 2026 · 8 likes Taking post #11 at face value and following it one step further. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether…
Official shortage notices and what they authorise Replied, post #39 · Access › Shortages · 8 May 2026 · 6 likes Post #35 and I disagree about the size of the effect, not about the direction. Shortages end and the notices are updated. Checking the current notice takes a minute and…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #32 · Devices › Syringes & needles · 5 May 2026 · 20 likes Coming back to post #28, because the follow-up matters more than the original answer. U-100 means the barrel is graduated for a solution containing one hundred units of…
Managing an unplanned gap in supply Replied, post #86 · Access › Shortages · 5 Apr 2026 · 1 like What I would tell a new member reading about managing an unplanned gap for the first time: the confident posts are not the reliable ones, and the reliable ones are…
Type 2 diabetes and the largest part of the evidence base Replied, post #54 · Clinical › Comorbidities · 3 Apr 2026 · 0 likes Type 2 diabetes is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Grapefruit: why this class is not the class that cares Replied, post #108 · Practice › Interactions · 1 Apr 2026 · 31 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #15 · Practice › Administration · 12 Mar 2026 · 0 likes Agreed on Air bubbles, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
The most common factual error about semaglutide on the internet — what changed since Replied, post #41 · Compounds › Semaglutide · 5 Mar 2026 · 16 likes On post #37 — agreed on the reasoning, with one qualification. Gallbladder events appear in the labelling for this class and are more common with larger, faster weight…
The lowest dose that does anything: is that a real question? Replied, post #30 · Practice › Dosing & titration · 3 Mar 2026 · 4 likes The useful distinction on lowest dose is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Measurement error in a self-reported exposure Replied, post #120 · Evidence › Study critique · 27 Feb 2026 · 7 likes Measurement error has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #5 · Practice › Administration · 27 Feb 2026 · 15 likes A request rather than an answer: could whoever has the primary source for Air bubbles post it? I have seen the claim three times this month and each version had lost a…
Request: export my own posts — one year on Replied, post #47 · Meta › Feature requests · 15 Feb 2026 · 12 likes No notes. Posting so the count is not one.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #4 · Compounds › Semaglutide · 11 Feb 2026 · 5 likes Adding the boring version of molecular mass of semaglutide, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #2 · marked as the solution · Compounds › Semaglutide · 11 Feb 2026 · 33 likes Adding the measurement that the opening post says would settle it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
Can a home kit substitute for a laboratory report? A careful no Replied, post #127 · Analytics › Home & field testing · 6 Feb 2026 · 13 likes Summarising the home kit substitute thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #95 · Practice › Side effects · 14 Jan 2026 · 3 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting. A…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #76 · Practice › Side effects · 11 Jan 2026 · 3 likes Noted, and I have changed what I was going to do on the strength of it.
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #10 · Research Methods › Statistics · 10 Jan 2026 · 33 likes Time-to-event analysis handles differing follow-up in a way a simple proportion cannot, which is why event rates and Kaplan-Meier estimates can differ. I have left out…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #29 · Evidence › Trials · 28 Dec 2025 · 8 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #8 · Regional › UK & Ireland · 23 Dec 2025 · 4 likes Picking up post #5: that is the part I would want checked first. Answering the Private prescribing question as asked, then the question I think is meant. As asked: yes,…
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #7 · Data & Tools › Calculators · 21 Dec 2025 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
[2026 update] Whether protein timing matters at a large deficit Replied, post #9 · Nutrition & Training › Protein & intake · 20 Dec 2025 · 6 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #15 · Compounds › Semaglutide · 11 Dec 2025 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #3 · Compounds › Oral incretins · 13 Nov 2025 · 2 likes Adding the measurement that post #2 says would settle it. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
Temperature loggers worth the money Replied, post #49 · Devices › Cold chain · 1 Nov 2025 · 26 likes Adding the boring version of temperature loggers worth the money, because the interesting version keeps getting posted and the boring one is usually right. Check the…
Reading SURMOUNT-1 without the press release Replied, post #33 · Compounds › Tirzepatide · 13 Oct 2025 · 0 likes Distinguishing three things in the reading SURMOUNT-1 without the press discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
Compounds this community declines to help with, and why Replied, post #59 · Compounds › Other compounds · 4 Oct 2025 · 9 likes Post #56 is right about the mechanism and I think understates the practical bit. Several compounds discussed here have no published human pharmacokinetics at all. That…
AOD-9604 and the fragment hypothesis, revisited Replied, post #18 · Compounds › Other compounds · 1 Oct 2025 · 0 likes Adding the measurement that post #17 says would settle it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #93 · Evidence › Study critique · 15 Sep 2025 · 2 likes Reverse causation has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #83 · Compounds › Retatrutide · 7 Sep 2025 · 21 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Titles that describe the question, not the situation — what changed since Started this topic · Start Here › How to Ask · 7 Sep 2025 · 0 likes Posting this under the heading it deserves: Titles that describe the question, not the situation — what changed since Everything below is what sits behind that. What…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #35 · Compounds › Tirzepatide · 3 Sep 2025 · 0 likes Good question, well framed, and I would like to see it answered properly.
Power cut for eleven hours: how I assessed it afterwards Replied, post #27 · Practice › Storage & stability · 18 Aug 2025 · 0 likes Building on post #25 rather than restating it. On power cut for eleven hours, the part that usually goes wrong is that the question is asked as though it has one…
When a preprint is the best available evidence and we say so Replied, post #47 · Evidence › Preprints · 12 Aug 2025 · 0 likes Narrowing post #44, because the general version has more than one answer. Where a preprint's numbers are the basis of a claim being repeated here, someone should check…
How to research a compound with no human data without deceiving yourself Replied, post #115 · Compounds › Other compounds · 5 Aug 2025 · 27 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #89 · Compounds › Retatrutide · 3 Aug 2025 · 2 likes The arithmetic in post #88 is right; the assumption feeding it is the part to check. What I would check first on Triple agonism is whether the thing being measured…
A field-by-field walk through a certificate of analysis Replied, post #56 · Analytics › COA interpretation · 16 Jul 2025 · 21 likes I would be cautious about generalising from the field-by-field walk through a certificate example above. It is a good example. It is one example.
Discussing something you have already been doing — the long version Replied, post #19 · Clinical › Prescriber conversations · 13 Jul 2025 · 7 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #53 · Compounds › Semaglutide · 3 Jul 2025 · 5 likes The arithmetic in post #50 is right; the assumption feeding it is the part to check. The thing about Semaglutide half-life that took me longest to accept is that a…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #69 · Clinical › Comorbidities · 19 Jun 2025 · 0 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. That is what the…
Substitution between formats during a shortage Replied, post #8 · Access › Shortages · 11 Jun 2025 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #7 · Compounds › Oral incretins · 6 Jun 2025 · 1 like Worth separating two things that post #3 runs together. Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #54 · Compounds › Repair & healing peptides · 5 Jun 2025 · 25 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the…
Which panel is worth repeating and which is worth ignoring Replied, post #29 · Clinical › Bloodwork · 31 May 2025 · 9 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial. The reasoning…
DXA precision and the least significant change for lean mass — the long version Replied, post #109 · Outcomes › Body composition · 28 May 2025 · 6 likes Photographs under fixed lighting and posture are a genuine record and are the hardest of these to standardise. If anyone can point at the primary source I would be…
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #28 · Meta › Wiki maintenance · 10 May 2025 · 17 likes Adding the measurement that post #25 says would settle it. The failure mode on Citation sweep results is boring rather than dramatic. It is almost always the step…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #35 · Sourcing › Independent verification · 8 May 2025 · 0 likes Answering the splitting a vial question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Regression to the mean in progress reports Replied, post #6 · Research Methods › Statistics · 3 May 2025 · 1 like Noted, and I have changed what I was going to do on the strength of it.
Reporting a disappointing outcome, and why it belongs here Replied, post #11 · Outcomes › Progress reports · 24 Apr 2025 · 0 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
When to suspect the method rather than the sample Replied, post #105 · Analytics › Method validation · 28 Mar 2025 · 5 likes No disagreement from me. Posting only so the question does not look ignored.
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #62 · Evidence › Journal club · 25 Mar 2025 · 28 likes One caution on SUSTAIN 6: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Review: a draft on reconstitution arithmetic, with objections Replied, post #70 · Documentation › Doc review · 22 Mar 2025 · 12 likes Two sentences on draft on reconstitution arithmetic and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #119 · Compounds › Other compounds · 19 Mar 2025 · 1 like I read post #116 twice before replying, because I had assumed the opposite. Speaking only to Research-use-only status as I have actually seen it, rather than as it is…
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #18 · Start Here › Welcome · 17 Mar 2025 · 19 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
Charge states for a 4 kDa peptide, worked through Replied, post #17 · Analytics › Mass spectrometry · 4 Mar 2025 · 13 likes Resolution: "high resolution" commonly means The short answer was in the first line; everything after is the working.
Adducts: sodium, potassium, and the peak you did not expect Replied, post #24 · Analytics › Mass spectrometry · 3 Mar 2025 · 32 likes Where the adducts discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #26 · Documentation › Doc review · 18 Jan 2025 · 1 like Where a review raises something the author disagrees with, recording the disagreement in the review thread is better than resolving it privately. Worth checking against…
Recovery when intake is low: what to cut first Replied, post #50 · Nutrition & Training › Resistance training · 12 Jan 2025 · 10 likes Counterpoint on recovery, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #124 · Compounds › Tirzepatide · 2 Jan 2025 · 33 likes Where I part company with post #122, and it is a narrow parting. Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks…
People with a low starting BMI: where the evidence stops Replied, post #27 · Clinical › Special populations · 26 Dec 2024 · 9 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
[2026 update] New subcategory: rationale and scope Replied, post #85 · Meta › Announcements · 22 Dec 2024 · 11 likes Two sentences on New subcategory and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
When "no data" is the complete and final answer Replied, post #47 · Compounds › Other compounds · 22 Dec 2024 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #28 · Practice › Side effects · 19 Nov 2024 · 14 likes Worth separating two things that post #24 runs together. Adding what did not work for me on nausea timeline, since the failures never get written up and they are half…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #27 · Sourcing › Independent verification · 11 Nov 2024 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Repeat determination on the same product line months apart is the measurement that…
Time to steady state after a dose increase Replied, post #114 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Worth separating two things that post #112 runs together. Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after…
Requesting a page: what makes a good request — what changed since Replied, post #60 · Documentation › Wiki requests · 11 Oct 2024 · 9 likes Post #57 is right about the mechanism and I think understates the practical bit. Say what would make the page wrong. A page whose failure conditions are stated is much…
Progressive overload when the scale is falling — one year on Replied, post #102 · Nutrition & Training › Resistance training · 28 Sep 2024 · 17 likes Post #98 put the caveat in the right place and I want to underline it. On Progressive overload: the maintained page in the documentation commons covers the general case…
Correlation in a self-tracked dataset: what it can support Replied, post #93 · Research Methods › Statistics · 24 Aug 2024 · 28 likes Post #91 answers the question as asked. The question underneath it is different. Number needed to treat: how many people need to be treated to prevent one bad outcome…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #9 · Practice › Dosing & titration · 6 Jul 2024 · 6 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
Assessing a warm arrival: the decision process — one year on Replied, post #80 · Sourcing › Logistics · 31 May 2024 · 4 likes Nothing to add on the substance. Thank you for taking the question at face value.